Edition:
United States

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

4,565JPY
22 Sep 2017
Change (% chg)

¥-10 (-0.22%)
Prev Close
¥4,575
Open
¥4,590
Day's High
¥4,590
Day's Low
¥4,550
Volume
670,400
Avg. Vol
855,910
52-wk High
¥4,735
52-wk Low
¥3,010

Chart for

About

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)

Overall

Beta: 0.64
Market Cap(Mil.): ¥2,560,563.00
Shares Outstanding(Mil.): 559.69
Dividend: 29.00
Yield (%): 1.20

Financials

  Industry Sector
P/E (TTM): -- 31.66 16.34
EPS (TTM): -- -- --
ROI: -- 15.09 14.66
ROE: -- 16.32 14.00

BRIEF-Chugai Pharmaceutical aims to increase core oper profit to more than 100 bln Yen in year ending Dec. 2019 - Nikkei

* Chugai Pharmaceutical Co Ltd aims to increase its core operating profit to more than 100 billion yen ($920 million) in the year ending December 2019 - Nikkei Source text (http://s.nikkei.com/2x6fubs) Further company coverage:

Aug 21 2017

BRIEF-Chugai Pharmaceutical sells trusted beneficial rights of property

* Says it has sold the trusted beneficial rights of Tokyo-based property on May 12

May 12 2017

BRIEF- Baxalta files lawsuit against Chugai Pharmaceutical and Genentech

* Says Baxalta filed a lawsuit against the company and Genentech Inc., in U.S. on May 4

May 10 2017

BRIEF-Chugai Pharmaceutical to retire treasury shares

* Says it will retire 123,000 shares (0.02 percent of outstanding) of its common stock on April 28

Apr 25 2017

BRIEF-Chugai Pharmaceutical to issue 123,000 shares for 469.9 mln yen

* Says it plans to issue 123,000 shares for 469.9 million yen in total

Mar 23 2017

Earnings vs. Estimates